- Home
- PLRZ vs SCNI Comparison
PLRZ vs SCNI Comparison
Compare PLRZ & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- SCNI
- Stock Information
- Founded
- PLRZ 2005
- SCNI 2003
- Country
- PLRZ Israel
- SCNI Israel
- Employees
- PLRZ N/A
- SCNI N/A
- Industry
- PLRZ
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLRZ
- SCNI Health Care
- Exchange
- PLRZ NYSE
- SCNI Nasdaq
- Market Cap
- PLRZ 3.7M
- SCNI 3.2M
- IPO Year
- PLRZ 2024
- SCNI N/A
- Fundamental
- Price
- PLRZ $0.69
- SCNI N/A
- Analyst Decision
- PLRZ
- SCNI
- Analyst Count
- PLRZ 0
- SCNI 0
- Target Price
- PLRZ N/A
- SCNI N/A
- AVG Volume (30 Days)
- PLRZ 3.0M
- SCNI 1.1M
- Earning Date
- PLRZ 02-15-2025
- SCNI 08-14-2025
- Dividend Yield
- PLRZ N/A
- SCNI N/A
- EPS Growth
- PLRZ N/A
- SCNI N/A
- EPS
- PLRZ N/A
- SCNI N/A
- Revenue
- PLRZ N/A
- SCNI $658,000.00
- Revenue This Year
- PLRZ N/A
- SCNI N/A
- Revenue Next Year
- PLRZ N/A
- SCNI N/A
- P/E Ratio
- PLRZ N/A
- SCNI N/A
- Revenue Growth
- PLRZ N/A
- SCNI N/A
- 52 Week Low
- PLRZ $0.55
- SCNI $1.90
- 52 Week High
- PLRZ $1,200.00
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- SCNI 42.95
- Support Level
- PLRZ N/A
- SCNI $2.12
- Resistance Level
- PLRZ N/A
- SCNI $2.85
- Average True Range (ATR)
- PLRZ 0.00
- SCNI 0.20
- MACD
- PLRZ 0.00
- SCNI 0.00
- Stochastic Oscillator
- PLRZ 0.00
- SCNI 11.37
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.